Consistently, western blot analysis demonstrated that the levels of pro-apoptotic protein Bax were markedly up-regulated but that anti-apoptotic Bcl-2 was significantly reduced by MASM in RA-FLS in a dose-dependent manner (Fig. 5B). The gene discussed is BCL2; the disease is rheumatoid arthritis.